γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
de Vries NL, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn ME, van der Ploeg M, van den Bulk J, Ruano D, van den Berg JG, Haanen JB, Zeverijn LJ, Geurts BS, de Wit GF, Battaglia TW, Gelderblom H, Verheul HMW, Schumacher TN, Wessels LFA, Koning F, de Miranda NFCC, Voest EE. · 2023
Read γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. by de Vries NL, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn ME, van der Ploeg M, van den Bulk J, Ruano D, van den Berg JG, Haanen JB, Zeverijn LJ, Geurts BS, de Wit GF, Battaglia TW, Gelderblom H, Verheul HMW, Schumacher TN, Wessels LFA, Koning F, de Miranda NFCC, Voest EE. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9876799.txt.
Description
de Vries and co-authors investigate γδ T cells in cancers that lack HLA class I presentation. The study focuses on mismatch repair-deficient cancers, which respond well to immune checkpoint blockade. Most such cancers stayed responsive even when B2M was lost. The team found 20 of 21 B2M-inactivated cancers still responded.
B2M loss was linked to greater infiltration by γδ T cells, mainly Vδ1 and Vδ3 types. These cells carried PD-1 and other activation and cytotoxic markers. In lab tests they reacted strongly to tumor cells lacking HLA class I. Checkpoint blockade raised their frequency further in B2M-deficient tumors. The findings point to γδ T cells as real effectors in this setting.
Catalog record
| CREATOR | de Vries NL, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn ME, van der Ploeg M, van den Bulk J, Ruano D, van den Berg JG, Haanen JB, Zeverijn LJ, Geurts BS, de Wit GF, Battaglia TW, Gelderblom H, Verheul HMW, Schumacher TN, Wessels LFA, Koning F, de Miranda NFCC, Voest EE. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |